Document is current
Any future updates will be listed below
-
Authors
Ohta, Yui
Tsuchiya, Takaaki
Oka, Masatoshi
Tachibana, Moriaki
Kondo, Yoshitaka
Fukushima, Kaoruko
Matsuno, Shiho
Yamanaka, Noriko
Suzuki, Noriyuki
Komatsu, Akiko
Rokutan, Hirofumi
Yumura, Wako
Arai, Tomio
Ishigami, Akihito
Itabashi, Mitsuyo
Takei, Takashi https://orcid.org/0000-0002-6283-8146
- License Information
-
More Information
Article History
Received: 16 October 2024
Accepted: 16 December 2024
First Online: 6 January 2025
Declarations
:
: The authors declare no conflicts of interest.
: The use of plasmapheresis, DFPP, rituximab, and bortezomib for the treatment of cryoglobulinemic vasculitis involved unapproved investigational drugs and was conducted with the approval of our institutional ethics committee. Written informed consent was obtained from the patient for the treatment and for the publication of this case report.
